Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment

YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA
Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
YUSUKE NIISATO
1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIKAZU MORIWAKI
1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tmoriwak@gmail.com
SHOTA FUKUOKA
2Division of Experimental Therapeutics, National Cancer Center, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIKI MASUISHI
3Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATSUO TAKASHIMA
4Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSUKE KUMEKAWA
5Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI KAJIWARA
6Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO YAMAZAKI
7Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAITO ESAKI
8Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKITAKA MAKIYAMA
9Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADAMICHI DENDA
10Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIMASA HATACHI
11Division of Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI SUTO
12Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOTOSHI SUGIMOTO
13Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO SHIMADA
14Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 4 2203-2207
DOI 
https://doi.org/10.21873/anticanres.14996
PubMed 
33813435

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 10, 2021
  • Revision received February 24, 2021
  • Accepted February 25, 2021
  • Published online April 3, 2021.

Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. YUSUKE NIISATO1,
  2. TOSHIKAZU MORIWAKI1⇑,
  3. SHOTA FUKUOKA2,
  4. TOSHIKI MASUISHI3,
  5. ATSUO TAKASHIMA4,
  6. YOSUKE KUMEKAWA5,
  7. TAKESHI KAJIWARA6,
  8. KENTARO YAMAZAKI7,
  9. TAITO ESAKI8,
  10. AKITAKA MAKIYAMA9,
  11. TADAMICHI DENDA10,
  12. YUKIMASA HATACHI11,
  13. TAKESHI SUTO12,
  14. NAOTOSHI SUGIMOTO13 and
  15. YASUHIRO SHIMADA14
  1. 1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
  2. 2Division of Experimental Therapeutics, National Cancer Center, Kashiwa, Japan;
  3. 3Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan;
  4. 4Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
  5. 5Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan;
  6. 6Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan;
  7. 7Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
  8. 8Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan;
  9. 9Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu, Japan;
  10. 10Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan;
  11. 11Division of Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan;
  12. 12Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan;
  13. 13Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan;
  14. 14Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
  1. Correspondence to: Toshikazu Moriwaki, MD, Ph.D., Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan. Tel/Fax: +81 298533218, e-mail: tmoriwak{at}gmail.com
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (4)
Anticancer Research
Vol. 41, Issue 4
April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO, YASUHIRO SHIMADA
Anticancer Research Apr 2021, 41 (4) 2203-2207; DOI: 10.21873/anticanres.14996

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO, YASUHIRO SHIMADA
Anticancer Research Apr 2021, 41 (4) 2203-2207; DOI: 10.21873/anticanres.14996
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Keywords

  • comorbidity
  • metastatic colorectal cancer
  • regorafenib
  • Trifluridine/tipiracil
  • TAS-102
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire